Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D-Shoulder appears to be a healthcare technology company or venture focused on integrated surgical software for shoulder arthroplasty. Publicly available information indicates it developed specialized 3D preoperative planning technology for anatomic and reverse shoulder replacement, including software later commercialized in partnership with Catalyst OrthoScience as Archer 3D Targeting. Available sources describe 3D-Shoulder as a joint venture involving 3D-Side and orthopedic executive Jean-Marie Berger, with the business positioned around personalized surgical planning rather than drug development. The company is not a biotech or pharma developer; it is better characterized as an orthopedic medical technology and surgical-planning software entity serving shoulder surgeons and implant companies. Evidence also suggests the brand may now be largely subsumed into or operated through 3D-Side's broader arthroplasty platform activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3D-Shoulder.